Clinical Trial Update: Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3) [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy trial evaluating a local antiviral treatment for high-grade cervical intraepithelial neoplasia (CIN2/3) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Snippet

Sponsor: Mithra Pharmaceuticals | Conditions: Uterine Cervical Neoplasia, Cervix Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED